Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Increased Body Temperature01:25

Increased Body Temperature

6.4K
A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
6.4K
Methods of reducing fever01:22

Methods of reducing fever

1.6K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.6K
Burn Injuries01:22

Burn Injuries

4.4K
Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.4K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

705
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
705
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.9K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
Healing I: Introduction01:11

Healing I: Introduction

14
Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
14

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-Autonomous Defense against Tuberculosis.

Cold Spring Harbor perspectives in medicine·2026
Same author

Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation.

EMBO molecular medicine·2026
Same author

Genes required for <i>Mycobacterium tuberculosis</i> to survive the transition from aerosol to pulmonary alveolar lining fluid and early infection in a model of transmission.

bioRxiv : the preprint server for biology·2025
Same author

ACOD1-mediated lysosomal membrane permeabilization contributes to <i>Mycobacterium tuberculosis</i>-induced macrophage death.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Candidate transmission survival genome of <i>Mycobacterium tuberculosis</i>.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Redirecting raltitrexed from cancer cell thymidylate synthase to <i>Mycobacterium tuberculosis</i> phosphopantetheinyl transferase.

Science advances·2024
Same journal

Geometric constraints on the architecture of mammalian cortical connectomes.

Cell·2026
Same journal

Iron drives protease-independent cleavage of gasdermin D in allergic airway diseases.

Cell·2026
Same journal

Excessive epithelial mechanosensation drives nociceptive innervation and chronic bladder pain via the PIEZO1-SLC7A11-glutamate axis.

Cell·2026
Same journal

Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment.

Cell·2026
Same journal

A disinhibitory basal forebrain-to-cortex projection supports sustained attention.

Cell·2026
Same journal

AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy.

Cell·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes
02:49

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes

Published on: February 23, 2024

2.4K

Nonresolving inflammation.

Carl Nathan1, Aihao Ding

  • 1Department of Microbiology and Immunology, Cornell University, New York, NY 10065, USA. cnathan@med.cornell.edu

Cell
|March 23, 2010
PubMed
Summary
This summary is machine-generated.

Persistent inflammation drives disease by damaging tissues. While the body has resolution mechanisms, their failure, especially in excessive or insufficient inflammatory responses, complicates anti-inflammatory therapy development.

More Related Videos

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

1.4K
Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
04:59

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia

Published on: May 30, 2025

2.2K

Related Experiment Videos

Last Updated: May 1, 2026

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes
02:49

Author Spotlight: A Multi-Depth Porcine Model for Comprehensive Study of Burn Injuries and Healing Processes

Published on: February 23, 2024

2.4K
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

1.4K
Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
04:59

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia

Published on: May 30, 2025

2.2K

Area of Science:

  • Immunology and Pathology
  • Molecular Biology
  • Biomedical Research

Background:

  • Nonresolving inflammation is a significant factor in disease development.
  • Inflammation can cause tissue damage, and necrosis can further provoke inflammatory responses.
  • Despite risks, the body possesses multiple mechanisms to ensure inflammatory resolution.

Purpose of the Study:

  • To explore the mechanisms underlying inflammatory resolution.
  • To identify factors contributing to the failure of inflammatory resolution.
  • To address challenges in developing anti-inflammatory therapies.

Main Methods:

  • Investigated cellular phenotype switching (e.g., macrophages).
  • Examined the role of secreted molecules (e.g., reactive oxygen intermediates) in modulating inflammation.
  • Identified emerging mediators of resolution, including proteins, lipids, and gasses.

Main Results:

  • Normal resolution involves coordinated shifts in cellular and molecular functions.
  • Failure to resolve can stem from initial inflammatory response intensity (excessive or subnormal).
  • Persistence of initiating stimuli also prevents resolution.

Conclusions:

  • Developing effective anti-inflammatory therapies is complex due to the multifaceted nature of inflammation resolution.
  • Conceptual, organizational, and statistical innovations are needed to advance anti-inflammatory drug development.
  • Understanding resolution pathways is crucial for treating inflammatory diseases.